BioHarvest Signs $20M–$30M Deal to Grow One of the World’s Costliest Perfume Ingredients in Bioreactors

Biomanufacturing company BioHarvest Sciences has secured an exclusive manufacturing and supply agreement to produce a rare fragrance compound for a customer in the United Arab Emirates. The contract aims to deliver 20 metric tons of the fragrance across 2027 and 2028, potentially generating between $20 million and $30 million in revenue. The compound, sourced from an endangered plant, is described as one of the most valuable fragrance raw materials in the world, with premium grades fetching high prices in luxury perfume markets.

BioHarvest's CEO, Dr. Zaki Rakib, sees the fragrance industry as an attractive target for the company's contract manufacturing arm due to high margins and fewer regulatory hurdles compared to food and pharmaceutical sectors. The company's Botanical Synthesis platform, which uses bioreactors to grow plant-derived compounds, has already expanded into food ingredients and is now venturing into the fragrance market. This move reflects BioHarvest's strategy to convert high-value opportunities into recurring revenue streams and sustainable profitability through its innovative technology.